Target intelligence / Profile preview

Interleukin-10 receptor 1 (IL-10R1)

Target
IL-10R1
Molecular classification
Receptor, Cytokine receptor, Class II cytokine receptor family
01

Overview

Interleukin-10 receptor 1 is a cell surface receptor that serves as the primary binding site for the anti-inflammatory cytokine interleukin-10 (IL-10)[1][3][4]. Structurally, it is a transmembrane glycoprotein composed of extracellular, transmembrane, and intracellular domains, and belongs to the class II cytokine receptor family[1][3]. Signal transduction occurs upon assembly of a heterodimeric receptor complex including IL-10R1 and the accessory protein IL-10R2 (IL-10RB); binding of IL-10 to IL-10R1 initiates intracellular signaling cascades—primarily JAK1/TYK2 kinases which phosphorylate STAT3—leading to suppression of inflammatory responses and promotion of regulatory and anti-apoptotic pathways[1][3][4]. The receptor is widely expressed on hematopoietic and immune cells, and its activity is essential for limiting the extent and duration of immune and inflammatory

Other names
IL-10RAIL10R1CD210Interleukin-10 receptor subunit alpha
02

Mechanism of action

Activation of Janus kinase 1 (JAK1) and Tyrosine kinase 2 (TYK2) following ligand binding leads to phosphorylation of STAT transcription factors, predominantly STAT3, driving anti-inflammatory gene expression and inhibition of pro-inflammatory cytokine signaling[1][3].

03

Biological functions

Immune response modulationSignal transductionRegulation of inflammationInhibition of pro-inflammatory cytokine productionPromotion of anti-apoptotic gene transcription
04

Disease associations

InflammationAutoimmune diseasesCancerInfectious diseases
05

Safety considerations

Potential for immunosuppression with chronic or excessive activation, increasing risk of infection or impaired tumor surveillancemodulation can affect host immune balance
06

Interacting drugs

No approved drugs directly target IL-10R1 (as per current clinical use), but therapeutic agents or biologics modulating IL-10 or the receptor are in research phases
07

Biomarkers

Expression of IL-10R1 in immune cells may serve as a biomarker in autoimmune diseases, inflammation, and cancer prognosislevels of phosphorylated STAT3 following IL-10 signaling may be used as a functional readout

Beyond the preview

Go deeper on Interleukin-10 receptor 1 (IL-10R1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Interleukin-10 receptor 1 (IL-10R1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call